These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Relevance of pharmacokinetics to prescribing in psychiatry. Ashton H; Harrison R Br J Hosp Med; 1994 Jun 1-14; 51(11):573, 576-80. PubMed ID: 7952746 [TBL] [Abstract][Full Text] [Related]
7. The challenges of psychopharmacogenetics. Catalano M Am J Hum Genet; 1999 Sep; 65(3):606-10. PubMed ID: 10441566 [No Abstract] [Full Text] [Related]
8. Pharmacogenetics. Promise and potential in child and adolescent psychiatry. Anderson GM; Cook EH Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):23-42, viii. PubMed ID: 10674189 [TBL] [Abstract][Full Text] [Related]
9. [Comments to the brochure "Genetic tests and drug monitoring" distributed by the Laboratoriet, Epilepsihospitalet in Dianalund]. Línnet K Ugeskr Laeger; 2004 Jan; 166(1-2):70-1; author reply 71. PubMed ID: 14752999 [No Abstract] [Full Text] [Related]
10. Perspectives and practical applications in psychopharmacogenetics. Mendlewicz J Prog Neuropsychopharmacol; 1979; 3(1-3):155-63. PubMed ID: 401337 [TBL] [Abstract][Full Text] [Related]
11. Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs. Stingl J; Viviani R J Intern Med; 2015 Feb; 277(2):167-177. PubMed ID: 25297512 [TBL] [Abstract][Full Text] [Related]
12. Contribution of allelic variations in transporters to the phenotype of drug response. Kirchheiner J; Gründemann D; Schömig E J Psychopharmacol; 2006 Jul; 20(4 Suppl):27-32. PubMed ID: 16785267 [TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of the pharmacogenetics in psychiatric and neurological syndromes]. Milejski P; Orzechowska-Juzwenko K Neurol Neurochir Pol; 1996; 30(6):997-1007. PubMed ID: 9173337 [TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 enzymes and psychiatric drugs. How a patient's genetic profile and other medications can alter drug response. Harv Ment Health Lett; 2009 Feb; 25(8):4-5. PubMed ID: 19241615 [No Abstract] [Full Text] [Related]
15. Is pharmacogenetic CYP2D6 testing useful? Vetti HH; Molven A; Eliassen AK; Steen VM Tidsskr Nor Laegeforen; 2010 Nov; 130(22):2224-8. PubMed ID: 21109842 [TBL] [Abstract][Full Text] [Related]
16. Developmental pharmacology. van den Anker JN Dev Disabil Res Rev; 2010; 16(3):233-8. PubMed ID: 20981761 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and psychopharmacotherapy. Poolsup N; Li Wan Po A; Knight TL J Clin Pharm Ther; 2000 Jun; 25(3):197-220. PubMed ID: 10886465 [TBL] [Abstract][Full Text] [Related]
18. Where are we today with personalized medicine? Howland RH J Psychosoc Nurs Ment Health Serv; 2012 Nov; 50(11):11-3. PubMed ID: 23066831 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacogenetics or the promise of a personalized medicine: variability in drug metabolism and transport]. Allorge D; Loriot MA Ann Biol Clin (Paris); 2004; 62(5):499-511. PubMed ID: 15355800 [TBL] [Abstract][Full Text] [Related]
20. Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence. van Hasselt FM; Coehorst Y; Wilffert B; Loonen AJ Pharmacopsychiatry; 2013 Mar; 46(2):43-6. PubMed ID: 23037948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]